96-13563. Importation of Controlled Substances; Notice of Application  

  • [Federal Register Volume 61, Number 105 (Thursday, May 30, 1996)]
    [Notices]
    [Pages 27099-27100]
    From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
    [FR Doc No: 96-13563]
    
    
    
    -----------------------------------------------------------------------
    
    
    DEPARTMENT OF JUSTICE
    
    Importation of Controlled Substances; Notice of Application
    
        Pursuant to Section 1008 of the Controlled Substances Import and 
    Export Act (21 U.S.C. 958(i)), the Attorney General shall, prior to 
    issuing a registration under this Section to a bulk manufacturer of a 
    controlled substance in Schedule I or II and prior to issuing a 
    regulation under Section 1002(a) authorizing the importation of
    
    [[Page 27100]]
    
    such a substance, provide manufacturers holding registrations for the 
    bulk manufacture of the substance an opportunity for a hearing.
        Therefore, in accordance with Section 1311.42 of Title 21, Code of 
    Federal Regulations (CFR), notice is hereby given that on January 8, 
    1996, Sanofi Withrop Inc., 200 East Oakton Street, Des Plaines, 
    Illinois 60018, made application to the Drug Enforcement Administration 
    to be registered as an importer of the basic classes of controlled 
    substances listed below:
    
    ------------------------------------------------------------------------
                               Drug                               Schedule  
    ------------------------------------------------------------------------
    Codeine (9050)............................................           II 
    Hydromorphone (9150)......................................           II 
    Meperidine (9230).........................................           II 
    Morphine (9300)...........................................           II 
    Fentanyl (9801)...........................................           II 
    ------------------------------------------------------------------------
    
        The firm plans to import the listed controlled substances for 
    distribution to its customers.
        Any manufacturer holding, or applying for, registration as a bulk 
    manufacturer of this basic class of controlled substance may file 
    written comments on or objections to the application described above 
    and may, at the same time, file a written request for a hearing on such 
    application in accordance with 21 CFR 1301.54 in such form as 
    prescribed by 21 CFR 1316.47.
        Any such comments, objections or requests for a hearing may be 
    addressed, in quintuplicate, to the Deputy Assistant Administrator, 
    Office of Diversion Control, Drug Enforcement Administration, United 
    States Department of Justice, Washington, D.C. 20537, Attention: DEA 
    Federal Register Representative (CCR), and must be filed no later than 
    July 1, 1996.
        This procedure is to be conducted simultaneously with and 
    independent of the procedures described in 21 CFR 1311.42 (b), (c), 
    (d), (e), and (f). As noted in a previous notice at 40 FR 43745-46 
    (September 23, 1975), all applicants for registration to import a basic 
    class of any controlled substance in Schedule I or II are and will 
    continue to be required to demonstrate to the Deputy Assistant 
    Administrator, Office of Diversion Control, Drug Enforcement 
    Administration that the requirements for such registration pursuant to 
    21 U.S.C. 958(a), 21 U.S.C. 823(a), and 21 CFR 1311.42 (a), (b), (c), 
    (d), (e), and (f) are satisfied.
    
        Dated: May 22, 1996.
    Gene R. Haislip,
    Deputy Assistant Administrator, Office of Diversion Control, Drug 
    Enforcement Administration.
    [FR Doc. 96-13563 Filed 5-29-96; 8:45 am]
    BILLING CODE 4410-09-M
    
    

Document Information

Published:
05/30/1996
Department:
Justice Department
Entry Type:
Notice
Document Number:
96-13563
Pages:
27099-27100 (2 pages)
PDF File:
96-13563.pdf